公司資料
Elevance Health 股價、新聞與催化劑
- 股票代碼:
- ELV
- 交易所:
- NYSE
- 產業:
- Biopharma
- 所在地:
- United States
股票表現
390.24 USD (-2.52%)
收盤價
最後更新: 2026年8月17日
84.5B USD
市值
股價為何變動
As of Aug 17, 2026, ELV closed down 2.52% at $390.24. No new same-company headline was identified in the current news window.
公司概覽
業務概覽
Elevance Health is a diversified healthcare company focused on health benefits, care delivery, and services. Its story is shaped by managed-care scale, medical cost discipline, and the breadth of its healthcare platform.
所在地與產業分類
Headquartered in the United States and listed on NYSE, Elevance is primarily a U.S.-focused managed-care company. Its footprint is broad across commercial, government, and specialty healthcare programs.
商業模式特徵
The business depends on premium revenue, healthcare services, and effective management of medical cost trends. Investors watch membership, pricing, care utilization, and operating discipline rather than drug-development catalysts.
生技產業定位
Elevance is not a biotech name, but it matters to healthcare investors because it sits at the payer-services core of the system. Its stock is driven by utilization and policy sensitivity, not clinical trial events.
未來催化劑
- Elevance Health’s catalysts are earnings, medical-benefit ratio commentary, and any update on Medicaid or Medicare utilization trends. This matters because it helps show whether the company can turn its current footprint into a cleaner earnings profile. Better execution here can matter even before a new product or trial headline lands.
近期新聞
相似股票
商業成熟度、治療領域或催化劑模式相近的同業公司。